Advertisement Pharmaceutical Business review - Page 12 of 5266 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
March 24, 2026

Kali and Sanofi sign licence agreement for KT501 autoimmune disease antibody

Sanofi has signed an exclusive global licence agreement with Kali Therapeutics for KT501, a new tri-specific antibody for B cell-mediated autoimmune diseases.

Continue
KT501 is an IgG-like tri-specific T-cell engager targeting CD3, CD19, and BCMA with high affinity. Credit: angellodeco / Shutterstock.com.
March 24, 2026

Monash University and ClinChoice partner on new therapies development

The collaboration brings together Monash’s research ecosystem with ClinChoice’s data science capabilities. Credit: CrizzyStudio / Shutterstock.com.
March 23, 2026

ImmunityBio receives Macau approval for Anktiva combo therapy

In the QUILT-3.032 study, Anktiva plus BCG achieved a 71% complete response rate. Credit: Stock-Asso / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. BMS secures FDA and EC approvals for Opdivo in Hodgkin Lymphoma
  2. Novartis to acquire SNV4818 from Synnovation
  3. Congruence secures $39.5m to advance small molecule correctors pipeline
  4. R1 Therapeutics raises $77.5m to progress AP306 for hyperphosphatemia
  5. FDA issues CRL to Aldeyra’s reproxalap drug application

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography